Free Trial

biote (BTMDW) Competitors

biote logo
$0.49 0.00 (0.00%)
(As of 11/14/2024 ET)

BTMDW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BCTXW

Should you be buying biote stock or one of its competitors? The main competitors of biote include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

biote vs.

180 Life Sciences (NASDAQ:ATNFW) and biote (NASDAQ:BTMDW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership, community ranking and earnings.

In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.87 beat biote's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
biote Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
biote$187.23MN/AN/AN/AN/A

180 Life Sciences and biote both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
bioteN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
biote N/A N/A N/A

Summary

180 Life Sciences and biote tied by winning 1 of the 2 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTMDW vs. The Competition

MetricbioteMedicinal Chemicals IndustryManufacturing SectorNASDAQ Exchange
Market CapN/AN/A$2.14B$8.88B
Dividend YieldN/AN/A2.65%4.04%
P/E RatioN/AN/A27.2517.46
Price / SalesN/AN/A489.4292.99
Price / CashN/AN/A53.6236.42
Price / BookN/AN/A2.385.86
Net IncomeN/AN/A$165.18M$225.23M
7 Day Performance-5.56%-5.56%-1.11%-0.89%
1 Month PerformanceN/A-4.87%0.03%3.72%
1 Year Performance-51.38%-51.38%11.10%26.41%

biote Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTMDW
biote
N/A$0.49
flat
N/AN/A$0.00$187.23M0.00N/A
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-2.0%$0.00N/A0.007Gap Down
High Trading Volume
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.05
flat
N/A+125.6%$0.00N/A0.002
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$65,122.000.0040Positive News
ALVOW
Alvotech
N/A$2.90
-3.3%
N/A+75.2%$0.00$306.77M0.004Short Interest ↓
Positive News
Gap Up
ALVO
Alvotech
2.1562 of 5 stars
$11.93
-1.9%
N/A+34.1%$0.00$93.38M-4.501,026Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.06
flat
N/AN/A$0.00N/A0.004Positive News
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/AN/A$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.05
-25.3%
N/A+208.9%$0.00$35.24M0.0070Positive News
Gap Up
BCTXW
BriaCell Therapeutics
N/A$0.27
flat
N/A-79.2%$0.00N/A0.008Short Interest ↓
Positive News

Related Companies and Tools


This page (NASDAQ:BTMDW) was last updated on 11/15/2024 by MarketBeat.com Staff
From Our Partners